Gastrointestinal Neoplasms
"Gastrointestinal Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the GASTROINTESTINAL TRACT, from the MOUTH to the ANAL CANAL.
| Descriptor ID |
D005770
|
| MeSH Number(s) |
C04.588.274.476 C06.301.371 C06.405.249
|
| Concept/Terms |
Gastrointestinal Neoplasms- Gastrointestinal Neoplasms
- Gastrointestinal Neoplasm
- Neoplasm, Gastrointestinal
- Neoplasms, Gastrointestinal
Cancer of Gastrointestinal Tract- Cancer of Gastrointestinal Tract
- Gastrointestinal Tract Cancer
- Gastrointestinal Tract Cancers
- Cancer of the Gastrointestinal Tract
- Gastrointestinal Cancer
- Cancer, Gastrointestinal
- Cancers, Gastrointestinal
- Gastrointestinal Cancers
|
Below are MeSH descriptors whose meaning is more general than "Gastrointestinal Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Gastrointestinal Neoplasms".
This graph shows the total number of publications written about "Gastrointestinal Neoplasms" by people in this website by year, and whether "Gastrointestinal Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2017 | 1 | 1 | 2 |
| 2018 | 1 | 0 | 1 |
| 2022 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Gastrointestinal Neoplasms" by people in Profiles.
-
Early steps on the pathway to develop quality metrics that have an impact on postendoscopy upper gastrointestinal cancer rates. Gastrointest Endosc. 2022 09; 96(3):476-478.
-
Risk of total metachronous advanced neoplasia in patients with both small tubular adenomas and serrated polyps. Gastrointest Endosc. 2022 07; 96(1):95-100.
-
KIT Exon 9-Mutated Gastrointestinal Stromal Tumours: Biology and Treatment. Chemotherapy. 2022; 67(2):81-90.
-
Avapritinib Versus Regorafenib in Locally Advanced Unresectable or Metastatic GI Stromal Tumor: A Randomized, Open-Label Phase III Study. J Clin Oncol. 2021 10 01; 39(28):3128-3139.
-
B Cell Lymphomas of the GI Tract. Curr Gastroenterol Rep. 2021 May 08; 23(7):9.
-
Gastrointestinal leiomyosarcoma demonstrate a predilection for distant recurrence and poor response to systemic treatments. Eur J Surg Oncol. 2021 10; 47(10):2595-2601.
-
Avapritinib in unresectable or metastatic PDGFRA D842V-mutant gastrointestinal stromal tumours: Long-term efficacy and safety data from the NAVIGATOR phase I trial. Eur J Cancer. 2021 03; 145:132-142.
-
Switch Control Inhibition of KIT and PDGFRA in Patients With Advanced Gastrointestinal Stromal Tumor: A Phase I Study of Ripretinib. J Clin Oncol. 2020 10 01; 38(28):3294-3303.
-
Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial. Lancet Oncol. 2020 07; 21(7):935-946.
-
Telemedicine During the COVID-19 Pandemic: Impact on Care for Rare Cancers. JCO Glob Oncol. 2020 07; 6:1046-1051.